Med24
metabolic-therapy 19. 10. 2026 • 2 min read • Disease models & mechanisms (PubMed)

Comprehensive cardiac, vascular, and pulmonary characterization of a cardiometabolic HFpEF model.

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome in which translational progress is limited by experimental models that insufficiently reflect the cardiometabolic phenotype while affecting endogenous endothelial function. We aimed to characterize a cardiometabolic...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

This research investigated a cardiometabolic model of heart failure with preserved ejection fraction (HFpEF) combining metabolic stress and chronic mineralocorticoid excess. The study aimed to characterize integrated cardiac, vascular, and pulmonary phenotypes.

Key Clinical Findings

Aldosterone-treated mice developed cardiac hypertrophy and pulmonary congestion despite maintaining a preserved left ventricular ejection fraction (LV). Diastolic dysfunction, left atrial remodeling with increased stiffness, and impaired global longitudinal LV strain were observed. Pulmonary hypertension with right ventricular dysfunction was evidenced, alongside elevated right ventricular systolic pressure relative to estimated mean pulmonary artery pressure.

Sponsored content

Model Significance

Endothelium-dependent relaxation was impaired in aortae from untreated mice, and this impairment was exacerbated by aldosterone, while endothelium-independent relaxation remained largely unaffected. The model replicated key features of cardiometabolic HFpEF across the cardiac-vascular-pulmonary axis. It provides a translational platform for studying endothelial and ventricular-vascular dysfunction. The model’s preservation of endogenous endothelial nitric oxide signaling offers a means to investigate vascular and cardiopulmonary mechanisms in this condition.

Original Scientific Source
Disease models & mechanisms (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement